RxDoctor Payments Data

Mercy Kanyongo

Family · Columbus, OHNPI 1174174627

Payments from drug & device makers

$4,507in general payments, 2019–2025

Across 157 payments — averaging $28.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Bayer$751
  • AbbVie$439
  • Lilly USA, LLC$437
  • Xeris Pharmaceuticals, Inc.$293
  • Dexcom, Inc.$290
  • plus $700 from 8 others

What the payments were for

  • Food & beverage$4,507100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,507 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$7,044
Medicare patients
22
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol33$28,579
TrulicityDulaglutide28$26,083
EliquisApixaban34$20,806
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$19,930
OzempicSemaglutide13$14,071
InvokanaCanagliflozin11$8,822
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$6,737
Spiriva HandihalerTiotropium Bromide12$5,158
Albuterol Sulfate HfaAlbuterol Sulfate163$3,607
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$1,652
Potassium Chloride86$1,024
Aripiprazole13$1,001
Naproxen24$962
Gabapentin140$827
Atorvastatin Calcium172$733

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,597$48,50955 claims
Lilly USA, LLCTrulicity$437$26,08328 claims
PfizerEliquis$236$20,80634 claims
Johnson & JohnsonInvokana$125$8,82211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →